
Videos









A recent study looking at data from three clinical trials involving Nerlynx shows promise for the future of treating patients with HER-2 positive breast cancer who develop CNS metastases.





The results of a phase 2 study looking at Padcev and Keytruda combination therapy for patients with metastatic urothelial cancer shows promise with a 73% response that did not differ for a patient ’s PDL1 status.









The incidence of colorectal and gastric cancers has risen for younger patients, and many of them share ethnic and socioeconomic disparities as well.

Take a look back at the top five CURE® stories for January 2020.

A subset of patients with metastatic pancreatic cancer and an inherited BRCA mutation rapidly progressed during a clinical trial of Lynparza.

Debbie Ryan was the head coach at a Division I women’s basketball program when she was diagnosed with pancreatic cancer in 2000. During treatment, she bonded with fellow pancreatic cancer patient Emily Couric, and together they outlined their ideal cancer center, now the Emily Couric Clinical Cancer Center.

A circulating cell-free DNA test for patients with gastrointestinal cancers has a 90% accuracy rate to detect patients’ cancers and could provide a standard test in the future, according to new study findings.

The combination treatment of Tecentriq (atezolizumab) and Avastain (bevacizumab) improved patient-reported outcomes and quality of life in a recent phase 3 study.

The cancer landscape has changed for patients with the introduction of targeted therapies, and a combination targeted therapy for some patients with colorectal cancer shows new promise.

After Scott Nelson was diagnosed with pancreatic cancer, his older brother Steve joined a pancreatic cancer screening study.